A detailed history of Versant Capital Management, Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 61 shares of GH stock, worth $2,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61
Holding current value
$2,188
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$20.2 - $38.11 $1,232 - $2,324
61 New
61 $1,000
Q2 2023

Jul 10, 2023

BUY
$20.94 - $38.01 $439 - $798
21 New
21 $0

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.67B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.